SLC2A13 and CYP4F2

Data Source:
BioGRID (two hybrid)

		SLC2A13	CYP4F2
Description		solute carrier family 2 member 13	cytochrome P450 family 4 subfamily F member 2
Image		No pdb structure	No pdb structure
GO Annotations	Cellular Component	Cytoplasm Lysosome Early Endosome Plasma Membrane Integral Component Of Plasma Membrane Synaptic Vesicle Membrane Growth Cone Organelle Membrane Cell Projection Intracellular Membrane-bounded Organelle Cell Body Cell Periphery Astrocyte End-foot	Cytoplasm Endoplasmic Reticulum Membrane Apical Plasma Membrane Intracellular Membrane-bounded Organelle
	Molecular Function	Protease Binding Myo-inositol Transmembrane Transporter Activity Myo-inositol:proton Symporter Activity Protein Binding ATPase Binding	Iron Ion Binding Protein Binding Arachidonic Acid Monooxygenase Activity Arachidonic Acid Epoxygenase Activity Oxidoreductase Activity, Acting On Paired Donors, With Incorporation Or Reduction Of Molecular Oxygen, NAD(P)H As One Donor, And Incorporation Of One Atom Of Oxygen Alkane 1-monooxygenase Activity Heme Binding Leukotriene-B4 20-monooxygenase Activity Arachidonic Acid Omega-hydroxylase Activity Alpha-tocopherol Omega-hydroxylase Activity Tocotrienol Omega-hydroxylase Activity Aromatase Activity
	Biological Process	Myo-inositol Transport Transmembrane Transport Transport Across Blood-brain Barrier Positive Regulation Of Amyloid-beta Formation	Very Long-chain Fatty Acid Metabolic Process Long-chain Fatty Acid Metabolic Process Renal Water Homeostasis Pressure Natriuresis Icosanoid Metabolic Process Leukotriene Metabolic Process Blood Coagulation Regulation Of Blood Pressure Drug Metabolic Process Arachidonic Acid Metabolic Process Epoxygenase P450 Pathway Negative Regulation Of Icosanoid Secretion Positive Regulation Of Icosanoid Secretion Leukotriene B4 Catabolic Process Vitamin E Metabolic Process Menaquinone Catabolic Process Phylloquinone Catabolic Process Vitamin K Catabolic Process Sodium Ion Homeostasis Omega-hydroxylase P450 Pathway
Pathways		Inositol transporters	Fatty acids Miscellaneous substrates Eicosanoids Synthesis of Leukotrienes (LT) and Eoxins (EX) Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)
Drugs
Diseases
GWAS		Alzheimer's disease in hypertension ( 31055733) Coronary artery calcification ( 23870195) Crohn's disease ( 28067908) Daytime sleep phenotypes ( 27126917) Disability (impaired activities of daily living) ( 31707593) Inflammatory bowel disease ( 28067908) Insomnia ( 23728906) Parkinson's disease ( 22451204 32201043 28011712) Putamen volume ( 31530798) Sleep quality ( 23728906)	Acenocoumarol maintenance dosage ( 19578179) Circulating phylloquinone levels ( 25411281) Metabolite levels ( 23281178) Response to Vitamin E supplementation ( 22437554) Urinary metabolite levels in chronic kidney disease ( 31959995) Urinary metabolite modules (eigenmetabolites) in chronic kidney disease ( 31959995) Vitamin E levels ( 21729881) Warfarin maintenance dose ( 20833655 19300499)
Interacting Genes		4 interacting genes: CYP4F2 FXYD6-FXYD2 PLP2 RIC8A	36 interacting genes: - AQP6 CPLX4 CREB3 CREB3L1 DNAJC1 EBP ELOVL4 ERGIC3 FAM210B FCER1G GJA8 HSD17B13 JAGN1 LEPROTL1 MMD MTIF3 MUC1 PGRMC2 PLEKHO1 REEP2 REEP4 RETREG3 SCN3B SDHAF2 SLC10A6 SLC17A8 SLC19A3 SLC2A13 THAP4 TLCD4 TM4SF19 TMEM51 TMEM82 TMX2 UBE2I
Entrez ID		114134	8529
HPRD ID		15363	05112
Ensembl ID		ENSG00000151229	ENSG00000186115
Uniprot IDs		Q96QE2	P78329
PDB IDs
Enriched GO Terms of Interacting Partners?
Tagcloud ?
Tagcloud (Difference) ?
Tagcloud (Intersection) ?